Breaking News

Bioserv Appoints Pharma Technologies SVP

April 21, 2014

Schrier brings 25 years of analytical and development experience

Jay Schrier, Ph.D., has been appointed senior vice president of Pharmaceutical Technologies at Bioserv Corp.

Dr. Schrier has more than 25 years of analytical and pharmaceutical development experience and has helped create numerous cGMP-compliant analytical and pharmaceutical development departments within the pharma industry. Prior to joining the company, he was senior director of pharmaceutical development at Pacira Pharmaceuticals.

Al Hansen, chairman and chief executive officer of Bioserv Corp. and managing partner at KESA Partners, said, “We are excited to welcome someone with Dr. Schrier’s outstanding qualifications and leadership skills to our growing executive team at Bioserv. His development expertise will result in significant value creation for our manufacturing clients. Dr. Schrier will provide expertise to our clients to enable them to manufacture their products to high quality standards but in a cost-effective manner.”

blog comments powered by Disqus
  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.